[Hemorheologic therapy of asystematic vertigo].
Hemorheological Treatment in Vertigo. Depending on data of hemorheology disturbances in risk factors (1.2.3.) and carotid artery arterosclerosis--progression in vertigo of non-vestibular origin (4.) this study evaluates treatment effects by basis, i.e. correction of risk factors only, versus additional hemorheological treatment (Lowering hct., HAES, Pentoxifylline) Patients: N = 88 fe. 51 m 37 age 25-86 mean 65.1.


RESULTS
++ base gr. 35% hemorh. 62% + base gr. 40% hem. 38% no effect base gr. 25% hemorh none.
Spürk
P
P
St. Vincenzkrankenhaus, Menden.
Dehnert
H G
HG
Angelkort
B
B
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016893:Carotid Stenosis / Q000097:blood* / Q000628:therapy*; D005260:Female; D006400:Hematocrit; D006438:Hemodilution / Q000379:methods*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage; D002537:Intracranial Arteriosclerosis / Q000097:blood* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010431:Pentoxifylline / Q000008:administration & dosage; D010889:Piracetam / Q000008:administration & dosage; D012212:Rheology; D014717:Vertigo / Q000097:blood / Q000209:etiology / Q000628:therapy*
D006895:Hydroxyethyl Starch Derivatives; D010431:Pentoxifylline; D010889:Piracetam
Hämorheologische Therapie des asystematischen Schwindels.